loading

Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie

pulisher
Dec 15, 2025

2 Monster Stocks in the Making - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

Castleark Management LLC Buys 19,250 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Axsome Therapeutics (AXSM) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com

Dec 15, 2025
pulisher
Dec 13, 2025

TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

RBC Capital Sticks to Its Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Dec 13, 2025
pulisher
Dec 13, 2025

Axsome Therapeutics, Inc. $AXSM Position Lowered by Eventide Asset Management LLC - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Bellevue Group AG Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Axsome Readies Alzheimer’s Drug Launch With Analyst Backing - Finimize

Dec 12, 2025
pulisher
Dec 12, 2025

Axsome Confident On Regulatory, Commercial Outlook for Alzheimer's Agitation Drug Candidate, RBC Says - marketscreener.com

Dec 12, 2025
pulisher
Dec 12, 2025

9,555 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by WINTON GROUP Ltd - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

How Investors Are Reacting To Axsome Therapeutics (AXSM) Revenue Surge Amid Wider Losses and Strategy Shift - Sahm

Dec 11, 2025
pulisher
Dec 11, 2025

Axsome Therapeutics, Inc. $AXSM Shares Sold by HighVista Strategies LLC - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

Invesco Ltd. Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

Russell Investments Group Ltd. Boosts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 11, 2025
pulisher
Dec 09, 2025

Axsome Therapeutics Stock Slips On Q4 Profit Miss, But Retail Takes It In Stride - MSN

Dec 09, 2025
pulisher
Dec 08, 2025

Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Jump Financial LLC Purchases 35,860 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Price-Driven Insight from (AXSM) for Rule-Based Strategy - news.stocktradersdaily.com

Dec 07, 2025
pulisher
Dec 07, 2025

Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 07, 2025
pulisher
Dec 07, 2025

Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 07, 2025
pulisher
Dec 07, 2025

Norges Bank Acquires New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 07, 2025
pulisher
Dec 06, 2025

Schroder Investment Management Group Has $3.91 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Affinity Asset Advisors LLC Has $5.22 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells 10,558 Shares of Stock - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Can Axsome Therapeutics Inc. (19X) stock sustain breakout momentum2025 Performance Recap & Fast Entry High Yield Tips - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Axsome Therapeutics Inc. stock outperform international peersCEO Change & Smart Money Movement Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Axsome Therapeutics Inc. stock recession proof2025 AllTime Highs & Reliable Trade Execution Plans - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Axsome therapeutics CEO Tabuteau sells $11.6 million in shares By Investing.com - Investing.com South Africa

Dec 04, 2025
pulisher
Dec 04, 2025

Axsome therapeutics CEO Tabuteau sells $11.6 million in shares - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Will Axsome Therapeutics Inc. (19X) stock outperform small cap peersEarnings Recap Summary & Growth Focused Investment Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Axsome Therapeutics Inc. stock outperform value stocksBull Run & Risk Controlled Swing Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Hsbc Holdings PLC Has $10.24 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Is Axsome Therapeutics Inc. (19X) stock trading at attractive multiplesWeekly Trade Report & High Yield Equity Trading Tips - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Rhumbline Advisers Has $6.45 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

What momentum indicators show for Axsome Therapeutics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Axsome Therapeutics Inc. (19X) stock included in top ETFsTrade Exit Report & Low Drawdown Trading Strategies - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Granite Investment Partners LLC Has $13.42 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

How Axsome Therapeutics Inc. (19X) stock trades pre earningsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Axsome Therapeutics, Inc. $AXSM Shares Purchased by Swiss National Bank - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

2 Under-the-Radar Stocks to Buy Heading Into 2026 - sharewise.com

Dec 02, 2025
pulisher
Dec 02, 2025

Axsome Therapeutics (AXSM): Evaluating Valuation Following Recent Share Price Momentum and Pipeline Expansion - Yahoo Finance

Dec 02, 2025
pulisher
Dec 01, 2025

2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool

Dec 01, 2025
pulisher
Dec 01, 2025

Axsome Therapeutics, Inc. $AXSM Shares Sold by Loomis Sayles & Co. L P - MarketBeat

Dec 01, 2025
pulisher
Dec 01, 2025

Quadrature Capital Ltd Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 01, 2025
pulisher
Dec 01, 2025

2,366 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Elevation Point Wealth Partners LLC - MarketBeat

Dec 01, 2025
pulisher
Dec 01, 2025

Capital Fund Management S.A. Buys 47,738 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Dec 01, 2025
pulisher
Nov 30, 2025

Jefferies Financial Group Inc. Makes New $261,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Nov 30, 2025
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):